Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,764 | 1,883 | 2,267 | 1,941 | 2,212 |
| Operating Income | -1,764 | -1,883 | -2,267 | -1,941 | -2,212 |
| Other Income | -30 | -76 | 39 | -130 | 20 |
| Pre-tax Income | -1,794 | -1,959 | -2,229 | -2,071 | -2,192 |
| Net Income Continuous | -1,794 | -1,959 | -2,229 | -2,071 | -2,192 |
| Net Income | $-1,794 | $-1,959 | $-2,229 | $-2,071 | $-2,192 |
| EPS Basic Total Ops | -2.00 | -4.50 | -8.50 | 11.00 | -9.50 |
| EPS Basic Continuous Ops | -2.02 | -4.61 | -8.52 | 10.89 | -9.39 |
| EPS Diluted Total Ops | -2.00 | -4.50 | -8.50 | 11.00 | -9.50 |
| EPS Diluted Continuous Ops | -2.02 | -4.61 | -8.52 | 10.89 | -9.39 |
| EPS Diluted Before Non-Recurring Items | -2.00 | -4.50 | -8.50 | -3.75 | -9.50 |
| EBITDA(a) | $-1,764 | $-1,883 | $-2,267 | $-1,941 | $-2,211 |